Castle study published through ASCO
Castle Biosciences published Uveal Melanoma patient data from genetic profiles.
“Long-term outcomes in a population-based cohort of 2,967 uveal melanoma patients clinically tested with the 15-gene expression profile: A collaborative study with the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program Registries.”